Strata Skin Sciences Stock Today

SSKN Stock  USD 0.44  0.02  4.35%   

Performance

0 of 100

 
Low
 
High
Very Weak

Odds Of Distress

Over 72

 
100  
 
Zero
High
STRATA Skin is selling at 0.44 as of the 28th of March 2024; that is -4.35% down since the beginning of the trading day. The stock's open price was 0.46. STRATA Skin has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for STRATA Skin Sciences are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 27th of February 2024 and ending today, the 28th of March 2024. Click here to learn more.
Business Domain
Health Care Equipment & Services
IPO Date
28th of October 2005
Category
Healthcare
Classification
Health Care
STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company has 35.05 M outstanding shares of which 217.93 K shares are at this time shorted by private and institutional investors with about 10.43 trading days to cover. More on STRATA Skin Sciences

Moving together with STRATA Stock

  0.64DYNT Dynatronics Financial Report 9th of May 2024 PairCorr
  0.7NEOG Neogen Report 4th of April 2024 PairCorr

Moving against STRATA Stock

  0.71NYXH Nyxoah Financial Report 21st of May 2024 PairCorr
  0.59CAH Cardinal Health Financial Report 2nd of May 2024 PairCorr
  0.54OMIC Singular Genomics Systems Financial Report 14th of May 2024 PairCorr
  0.52FEMY Femasys Report 4th of April 2024 PairCorr
  0.44NVNO EnVVeno Medical Corp Financial Report 6th of May 2024 PairCorr

STRATA Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. STRATA Skin's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding STRATA Skin or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
CEO PresidentDolev Rafaeli
Business ConcentrationHealth Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors)
Average Analyst Recommendation
Analysts covering STRATA Skin report their recommendations after researching STRATA Skin's financial statements, talking to executives and customers, or listening in on STRATA Skin's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering STRATA Skin Sciences. The STRATA consensus assessment is calculated by taking the average forecast from all of the analysts covering STRATA Skin.
Financial Strength
Based on the analysis of STRATA Skin's profitability, liquidity, and operating efficiency, STRATA Skin Sciences is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April. Financial strength of STRATA Skin Sciences is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover0.340.62
Way Down
Slightly volatile
Total Current Liabilities16.2 M15.4 M
Sufficiently Up
Slightly volatile
Non Current Liabilities Total20.5 M19.6 M
Sufficiently Up
Slightly volatile
Total Assets63.1 M60.1 M
Sufficiently Up
Slightly volatile
Total Current Assets17.2 M20.1 M
Fairly Down
Slightly volatile
STRATA Skin's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to STRATA Skin's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand STRATA Skin's financial leverage. It provides some insight into what part of STRATA Skin's total assets is financed by creditors.
By using current balance sheet information, investors can analyze the liability, assets, and equity on STRATA Skin's books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how STRATA Skin deploys its capital and how much of that capital is borrowed.
Liquidity
STRATA Skin cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company currently holds 8.44 M in liabilities with Debt to Equity (D/E) ratio of 0.35, which is about average as compared to similar companies. STRATA Skin Sciences has a current ratio of 1.27, suggesting that it may have difficulties to pay its financial obligations when due. Debt can assist STRATA Skin until it has trouble settling it off, either with new capital or with free cash flow. So, STRATA Skin's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like STRATA Skin Sciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for STRATA to invest in growth at high rates of return. When we think about STRATA Skin's use of debt, we should always consider it together with cash and equity.

Other Non Cash Items

145,350
STRATA Skin Sciences (SSKN) is traded on NASDAQ Exchange in USA. It is located in 5 Walnut Grove Drive, Horsham, PA, United States, 19044 and employs 114 people. STRATA Skin is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 15.6 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate STRATA Skin's market, we take the total number of its shares issued and multiply it by STRATA Skin's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. STRATA Skin Sciences conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 35.05 M outstanding shares of which 217.93 K shares are at this time shorted by private and institutional investors with about 10.43 trading days to cover. STRATA Skin Sciences currently holds about 10.04 M in cash with (2.03 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.29.
Check STRATA Skin Probability Of Bankruptcy
Ownership Allocation
STRATA Skin Sciences shows a total of 35.05 Million outstanding shares. Over half of STRATA Skin's outstanding shares are owned by institutional holders. These institutional holders are typically referred to as corporate investors that take positions in a given instrument to benefit from reduced trade commissions. Accordingly, these institutions are subject to different rules and regulations than regular investors in STRATA Skin Sciences. Please watch out for any change in the institutional holdings of STRATA Skin as this could mean something significant has changed or is about to change at the company. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check STRATA Ownership Details

STRATA Stock Price Odds Analysis

Contingent on a normal probability distribution, the odds of STRATA Skin jumping above the current price in 90 days from now is close to 99%. The STRATA Skin Sciences probability density function shows the probability of STRATA Skin stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days STRATA Skin Sciences has a beta of -0.1128. This usually implies as returns on benchmark increase, returns on holding STRATA Skin are expected to decrease at a much lower rate. During the bear market, however, STRATA Skin Sciences is likely to outperform the market. Additionally, sTRATA Skin Sciences has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming NYSE Composite.
  Odds Below 0.44HorizonTargetOdds Above 0.44
0.46%90 days
 0.44 
99.54%
Based on a normal probability distribution, the odds of STRATA Skin to move above the current price in 90 days from now is close to 99 (This STRATA Skin Sciences probability density function shows the probability of STRATA Stock to fall within a particular range of prices over 90 days) .

STRATA Stock Institutional Holders

Institutional Holdings refers to the ownership stake in STRATA Skin that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of STRATA Skin's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing STRATA Skin's value.
InstituionRecorded OnShares
Chicago Partners Investment Group Llc2023-12-31
64.2 K
Pnc Financial Services Group Inc2023-09-30
31.7 K
Northern Trust Corp2023-12-31
27.2 K
State Street Corporation2023-12-31
11.4 K
Tower Research Capital Llc2023-12-31
10.8 K
Carmichael Hill & Associates Inc2023-12-31
K
Jpmorgan Chase & Co2023-12-31
634
Morgan Stanley - Brokerage Accounts2023-12-31
510
Royal Bank Of Canada2023-12-31
320
Nantahala Capital Management, Llc2023-12-31
6.3 M
22nw, Lp2023-12-31
5.4 M
View STRATA Skin Diagnostics

STRATA Skin Historical Income Statement

STRATA Skin Sciences Income Statement is one of the three primary financial statements used for reporting STRATA's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of STRATA Skin Sciences revenue and expense. STRATA Skin Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, STRATA Skin's Other Operating Expenses is very stable compared to the past year. As of the 28th of March 2024, EBITDA is likely to grow to about 1.4 M, while Total Revenue is likely to drop about 19.8 M. View More Fundamentals

STRATA Stock Against Markets

Picking the right benchmark for STRATA Skin stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in STRATA Skin stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for STRATA Skin is critical whether you are bullish or bearish towards STRATA Skin Sciences at a given time. Please also check how STRATA Skin's historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in STRATA Skin without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Commodity Directory Now

   

Commodity Directory

Find actively traded commodities issued by global exchanges
All  Next Launch Module

STRATA Skin Corporate Directors

STRATA Skin corporate directors refer to members of a STRATA Skin board of directors. The board of directors generally takes responsibility for the STRATA Skin's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of STRATA Skin's board members must vote for the resolution. The STRATA Skin board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.

How to buy STRATA Stock?

Before investing in STRATA Skin, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in STRATA Skin. To buy STRATA Skin stock, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of STRATA Skin. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase STRATA Skin stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located STRATA Skin Sciences stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased STRATA Skin Sciences stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as STRATA Skin Sciences, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy STRATA Stock please use our How to Invest in STRATA Skin guide.

Already Invested in STRATA Skin Sciences?

The danger of trading STRATA Skin Sciences is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of STRATA Skin is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than STRATA Skin. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile STRATA Skin Sciences is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether STRATA Skin Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of STRATA Skin's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Strata Skin Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Strata Skin Sciences Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in STRATA Skin Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in industry.
You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Complementary Tools for STRATA Stock analysis

When running STRATA Skin's price analysis, check to measure STRATA Skin's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy STRATA Skin is operating at the current time. Most of STRATA Skin's value examination focuses on studying past and present price action to predict the probability of STRATA Skin's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move STRATA Skin's price. Additionally, you may evaluate how the addition of STRATA Skin to your portfolios can decrease your overall portfolio volatility.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Is STRATA Skin's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of STRATA Skin. If investors know STRATA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about STRATA Skin listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.20)
Revenue Per Share
1.012
Quarterly Revenue Growth
(0.06)
Return On Assets
(0.06)
Return On Equity
(0.38)
The market value of STRATA Skin Sciences is measured differently than its book value, which is the value of STRATA that is recorded on the company's balance sheet. Investors also form their own opinion of STRATA Skin's value that differs from its market value or its book value, called intrinsic value, which is STRATA Skin's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because STRATA Skin's market value can be influenced by many factors that don't directly affect STRATA Skin's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between STRATA Skin's value and its price as these two are different measures arrived at by different means. Investors typically determine if STRATA Skin is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, STRATA Skin's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.